文献速递间质性肺疾病

特发性肺纤维化患者端粒综合征肺外表现与生存期缩短相关

Extrapulmonary manifestations of a telomere syndrome in patients with idiopathic pulmonary fibrosis are associated with decreased survival.
PubMed 文献 · Respirology · 2022-04-13

该回顾性研究纳入409例特发性肺纤维化(IPF)患者,评估提示端粒综合征的肺外表现(临床病史、家族史、血液学异常)与白细胞端粒长度及生存的关系。27%的IPF患者存在任一或组合的提示端粒综合征的表现,且与更短的白细胞端粒长度和更短的生存期相关(多变量模型P=0.002)。在散发性IPF中,该关联未达统计学显著性(多变量模型P=0.07)。

要点

  • 27%的IPF患者存在提示端粒综合征的肺外表现、家族史或血液学异常。
  • 这些表现与更短的白细胞端粒长度和更短的生存期相关(多变量P=0.002)。
  • 详细采集肺外表现及家族史可为IPF患者提供重要预后信息。

核心结论

  • 仔细采集以端粒综合征肺外表现为重点的临床和家族史可为IPF患者提供重要预后信息,因其与更短生存期相关。

研究设计与样本

  • 回顾性研究纳入409例IPF患者,其中散发性IPF 293例,家族性肺纤维化背景116例。
  • 将提示端粒综合征的临床特征、实验室结果和家族史与定量PCR测定的白细胞端粒长度及患者结局进行关联分析。

主要发现

  • 27%的IPF患者存在任一或组合的提示端粒综合征的临床病史、家族史或血液学实验室异常。
  • 这些表现与更短的白细胞端粒长度和更短的生存期相关(多变量模型P=0.002)。
  • 在散发性IPF中,存在临床病史、家族史或血液学实验室异常与生存期缩短无显著关联(多变量模型P=0.07)。

关键数值与推荐

  • 提示端粒综合征的临床病史包括血液系统疾病、肝脏疾病、早白发、指甲营养不良、皮肤异常。
  • 提示端粒综合征的血液学实验室异常包括大细胞增多症、贫血、血小板减少或白细胞减少。

临床怎么用

  • 对IPF患者应详细采集以端粒综合征肺外表现为重点的临床病史和家族史以获取预后信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Idiopathic pulmonary fibrosis (IPF) is a heterogenous disease with a median survival of 3-4 years. Patients with mutations in telomere-related genes exhibit extrapulmonary signs and symptoms. These patients represent a distinct phenotype of IPF with worse survival. As genetic analyses are not available for most patients with IPF, we sought to determine the predictive value of extrapulmonary signs and symptoms of a telomere syndrome in patients with IPF. METHODS: We retrospectively studied 409 patients with IPF. Clinical characteristics, laboratory results and family history suggestive of a telomere syndrome were related to leukocyte telomere length measured by quantitative PCR and patient outcomes. RESULTS: The cohort included 293 patients with sporadic IPF and 116 patients with a background of familial pulmonary fibrosis. Any or a combination of a clinical history (haematological disease, liver disease, early greying of hair, nail dystrophy, skin abnormalities), a family history or haematological laboratory abnormalities (macrocytosis, anaemia, thrombopenia or leukopenia) suggestive of a telomere syndrome was present in 27% of IPF patients and associated with shorter leukocyte telomere length and shorter survival (p = 0.002 in a multivariate model). In sporadic IPF, having either a clinical history, family history or haematological laboratory abnormalities was not significantly associated with decreased survival (p = 0.07 in a multivariate model). CONCLUSION: Taking a careful clinical and family history focused on extrapulmonary manifestations of a telomere syndrome can provide important prognostic information in patients with IPF, as this is associated with shorter survival.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Hoffman TW, van der Vis JJ, Biesma DH, et al. Extrapulmonary manifestations of a telomere syndrome in patients with idiopathic pulmonary fibrosis are associated with decreased survival. Respirology. 2022. PMID: 35419815. doi:10.1111/resp.14264

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。